Skip to content
healthcare.dev

acetylcysteine

NDC 0574-0805, Acetylcysteine, injection, from Padagis US LLC.

Product NDC
0574-0805
Status
Listed
Labeler
Padagis US LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021539
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0805 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETYLCYSTEINE200 mg/mL

Pharmacologic classes

Antidote [EPC]; Antidote for Acetaminophen Overdose [EPC]; Decreased Respiratory Secretion Viscosity [PE]; Increased Glutathione Concentration [PE]; Mucolytic [EPC]; Reduction Activity [MoA]

Package NDCNDC-11Package
0574-0805-30005740805304 VIAL in 1 CARTON (0574-0805-30) / 30 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9d305722-e74f-4f48-8d2c-0daa99144749
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0574-0805

Use it

Look up 0574-0805 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0805 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0574-0805. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.